We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

69 hedge funds and large institutions have $614M invested in Dyne Therapeutics in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

146% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 13

44% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 9

38% more funds holding

Funds holding: 50 → 69 (+19)

12% more capital invested

Capital invested by funds: $550M → $614M (+$64.9M)

3.95% more ownership

Funds ownership: 60.52% → 64.47% (+4%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
69
Holders Change
+19
Holders Change %
+38%
% of All Funds
1.22%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
32
Increased
13
Reduced
9
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$14.5M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$12.8M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$7.16M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.67M
5
WP
Woodline Partners
California
+$4.43M

Top Sellers

1
SAM
Sectoral Asset Management
Quebec, Canada
-$9.58M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$7.04M
3
Franklin Resources
Franklin Resources
California
-$4.85M
4
FCM
Farallon Capital Management
California
-$4.04M
5
Millennium Management
Millennium Management
New York
-$3.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$3.41M +$3.21M +162,310 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$3.15M +$950K +48,006 +47%
Fidelity Investments
28
Fidelity Investments
Massachusetts
$2.47M – – –
HMC
29
Harvard Management Company
Massachusetts
$2.25M – – –
ACH
30
ArrowMark Colorado Holdings
Colorado
$2.1M -$1.98M -100,000 -50%
SFM
31
Sphera Funds Management
Israel
$2.1M +$593K +30,000 +43%
Charles Schwab
32
Charles Schwab
California
$1.73M +$1.63M +82,276 New
Alyeska Investment Group
33
Alyeska Investment Group
Illinois
$1.65M +$977K +49,371 +169%
Goldman Sachs
34
Goldman Sachs
New York
$939K -$2.64M -133,268 -75%
Ensign Peak Advisors
35
Ensign Peak Advisors
Utah
$840K – – –
Millennium Management
36
Millennium Management
New York
$810K -$3.08M -155,475 -80%
CS
37
Credit Suisse
Switzerland
$781K +$393K +19,845 +114%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$658K +$620K +31,349 New
TD Asset Management
39
TD Asset Management
Ontario, Canada
$579K – – –
Stifel Financial
40
Stifel Financial
Missouri
$547K +$515K +26,038 New
Two Sigma Advisers
41
Two Sigma Advisers
New York
$512K +$483K +24,400 New
Morgan Stanley
42
Morgan Stanley
New York
$510K +$480K +24,275 New
HS
43
HighVista Strategies
Massachusetts
$499K +$470K +23,760 New
N
44
Nuveen
North Carolina
$490K +$461K +23,318 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$452K +$426K +21,524 New
TRSOTSOK
46
Teachers Retirement System of the State of Kentucky
Kentucky
$311K – – –
Bank of America
47
Bank of America
North Carolina
$265K +$250K +12,639 New
BIM
48
Bogle Investment Management
Massachusetts
$253K +$238K +12,048 New
Deutsche Bank
49
Deutsche Bank
Germany
$250K +$235K +11,884 New
Tudor Investment Corp
50
Tudor Investment Corp
Connecticut
$226K -$53.6K -2,708 -20%
1
2
3 4

DYN Hedge Fund Activity: Q4 2020 in Review

69 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q4 2020, worth a combined $614M — up 12% from $550M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new DYN positions and 13 closed out — a net gain of 19 holders — while 13 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $14.5M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $9.58M sold.

  • 69 institutional investors held Dyne Therapeutics (DYN) as of Q4 2020, up from 50 in Q3 2020.
  • Funds reported $614M of Dyne Therapeutics stock for Q4 2020, up 12% quarter-over-quarter.
  • 32 funds opened new Dyne Therapeutics positions in Q4 2020 and 13 closed out, a net change of +19 holders.
  • The largest Dyne Therapeutics buyer in Q4 2020 was BlackRock, an estimated $14.5M added.
  • The largest Dyne Therapeutics seller in Q4 2020 was Sectoral Asset Management, an estimated $9.58M sold.

Based on aggregated 13F filings for Q4 2020.